Drug
Icp 105
Icp 105: highest development phase Phase 1, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-105 NCT03642834 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Icp 105 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.